StealthGas Inc. 

(Public, NASDAQ:GASS)   Watch this stock   
Find more results for GASS
Nov 17, 2009
Q3 2009 STEALTHGAS INC Earnings Conference Call
Nov 16, 2009
Q3 2009 STEALTHGAS INC Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 25.22% 26.64%
Operating margin 23.86% 37.39%
EBITD margin - 58.07%
Return on average assets 4.24% 5.39%
Return on average equity 8.81% 9.66%
Employees 417 -

Address

331 Kifissias Avenue Erithrea
Athens 14561,
Greece
+30-210-6252849 (Phone)
+30-210-6250018 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

StealthGas Inc. discussions

  View all discussions »

Description

StealthGas Inc. (StealthGas) owns a fleet of liquefied petroleum gas (LPG) carriers providing international seaborne transportation services to LPG producers and users, as well as product tankers chartered to oil producers and refiners. The Company carries various petroleum gas products in liquefied form, including propane, butane, butadiene, isopropane, propylene and vinyl chloride monomer, which are all by-products of the production of crude oil and natural gas. As of June 15, 2009, the Company’s fleet included 39 LPG carriers with an average age of 11.1 years and two product carriers. In addition, as of June 15, 2009, StealthGas had contracted to acquire one resale newbuilding LPG carrier, five newbuilding LPG carriers and two resale newbuilding medium range product carriers.

Officers and directors

Michael G. Jolliffe
Chairman of the Board
Age: 59
Bio & Compensation - Reuters
Harry N. Vafias
President, Chief Executive Officer, Director
Age: 31
Bio & Compensation - Reuters
Lambros Babilis
Deputy Chairman of the Board
Age: 41
Bio & Compensation - Reuters
Andrew J. Simmons
Chief Financial Officer
Age: 53
Bio & Compensation - Reuters
Thanassis J. Martinos
Director
Age: 59
Bio & Compensation - Reuters
Markos Drakos
Director
Age: 49
Bio & Compensation - Reuters